To explore the effectiveness of platelet-rich plasma (PRP) in treating cartilage degenerative pathology in knee joints.
Electronic databases, including PubMed and Scopus, were searched from the earliest record to September 2013.
We included single-arm prospective studies, quasi-experimental, and randomized controlled trials that employed PRP to treat knee chondral degenerative lesions. Eight single-arm studies, 3 quasi-experimental, and 5 randomized controlled trials were identified, comprising 1543 participants.
We determined effect sizes for the selected studies by extracting changes in functional scales following the interventions and compared the PRP group pooled values with the pre-treatment baseline and the groups receiving placebo or hyaluronic acid (HA) injections.
PRP injections in patients with knee degenerative pathology showed continual efficacy for 12 months compared with their pre-treatment condition. The effectiveness of PRP was likely better and more prolonged than HA. Injection doses equal to or less than 2, the use of a single-spinning approach, and lack of additional activators led to an uncertainty in the treatment effects. Patients with lower degrees of cartilage degeneration achieved superior outcomes as opposed to those affected by advanced osteoarthritis.
PRP application improves function from basal evaluations in patients with knee joint cartilage degenerative pathology and tends to be more effective than HA administration. Discrepancy in the degenerative severity modifies the treatment responses, leading to participants with lower degrees of degeneration to benefit more from PRP injections.